Studies suggest the prevalence of deficiency in the UK is one in 10 people aged 75 and over, one in 20 aged 65-74, and lower in younger age groups except for vegans, where prevalence is around 11%
But if your goal, as is the case in most dedicated research, is to explore the absolute maximum potential for tissue regeneration and recovery, the evidence strongly suggests that these two should be kept far apart
\n\n\n\n Studies have also found that BPC-157 protects gastric mucosa from damage induced by alcohol, NSAIDs, and chronic stress in rodent models a finding with significant implications for research into drug-induced gastrointestinal injury, which remains a major clinical problem worldwide
However, new senescent cells continue to accumulate with ongoing aging, meaning the benefits would be expected to gradually diminish over time without retreatment